Block on Trump's Asylum Ban Upheld by Supreme Court
In a False Claims Act action claiming that defendant engaged in an off-label marketing campaign to increase sales of Marinol, a synthetic form of THC, for purposes not approved by the Food and Drug Administration (FDA), dismissal of the complaint is affirmed where the court was unable to discern from the complaint a specific person or entity that was alleged to have presented a claim of any kind, let alone a false or fraudulent claim.
Filed December 4, 2009
Opinion by Judge Cox
Sign into your Legal Forms and Services account to manage your estate planning documents.Sign In
Create an account allows to take advantage of these benefits: